Reveal HealthTech positions itself as a 'healthcare AI specialist' at the intersection of cutting-edge AI and deep healthcare expertise, helping providers and life sciences organizations adopt AI through both products and technology consulting, AI model development, and workflow automation. Its flagship products include BioCanvas, which accelerates clinical trial recruitment, and Prism AI, which automates workflows across healthcare operations. Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company employs around 120 people across the U.S. and India, with a team drawn from MIT, Harvard Medical, UC Berkeley, Boston Children's, Mass General, SpaceX, NASA, and Athenahealth. In September 2025, Reveal HealthTech raised a $7.2M Series A led by Leo Capital, with Sanos Capital participating, to expand its capabilities, strengthen its sales network, and broaden its reach across healthcare and life sciences.